Call Now

Basilar Arterial Thrombosis (BAT)

Acute basilar artery thrombosis (ABT) has been largely considered a neurological catastrophe. With conventional treatment, only around 20% of patients achieve functional independence. An early presumptive diagnosis is essential to avoid treatment delay. Either multiparametric magnetic resonance imaging or computed tomography angiography source images may represent valid non-invasive tools to confirm ABT and evaluate ischemic tissue viability. The main determinant of ABT outcome is early recanalization but the most effective therapeutic option remains to be clarified. The BASICS prospective registry showed no superiority of intra-arterial over intravenous thrombolysis.

Organism species: Pan-species (General)

PRODUCT TYPE CATALOG NO. PRODUCT NAME APPLICATIONS
Proteins N/A Recombinant Basilar Arterial Thrombosis (BAT) Antigenic Transformation Customized Service Offer
Antibodies N/A Monoclonal Antibody to Basilar Arterial Thrombosis (BAT) Monoclonal Antibody Customized Service Offer
N/A Polyclonal Antibody to Basilar Arterial Thrombosis (BAT) Polyclonal Antibody Customized Service Offer
Assay Kits N/A CLIA Kit for Basilar Arterial Thrombosis (BAT) CLIA Kit Customized Service Offer
N/A ELISA Kit for Basilar Arterial Thrombosis (BAT) ELISA Kit Customized Service Offer